(Q39292752)

10 September 2017

title

Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone (English)

1 reference

10 September 2017

1 reference

1 reference

Mikko Neuvonen

4

0 references

Pertti J. Neuvonen

object named as

Pertti J Neuvonen

6

0 references

Nora Hagelberg

3

object named as

Nora M Hagelberg

1 reference

10 September 2017

Teijo I Saari

1

1 reference

10 September 2017

Juha Grönlund

2

1 reference

10 September 2017

Kari Laine

5

1 reference

10 September 2017

Klaus T Olkkola

7

1 reference

10 September 2017

publication date

1 April 2010

1 reference

European Journal of Clinical Pharmacology

10 September 2017

published in

1 reference

10 September 2017

volume

66

1 reference

10 September 2017

issue

4

1 reference

10 September 2017

page(s)

387-397

1 reference

https://scigraph.springernature.com/pub.10.1007/s00228-009-0775-8

10 September 2017

exact match

0 references

cites work

The pharmacokinetics and metabolism of oxycodone after intramuscular and oral administration to healthy subjects

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0775-8

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0775-8

The pharmacokinetics of oxycodone after intravenous injection in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0775-8

Pencil and paper tests-sensitivity to psychotropic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-009-0775-8

Predicting aberrant drug behavior in patients treated for chronic pain: importance of abuse history

21 January 2018

1 reference

12 December 2020

Determination of oxycodone, noroxycodone, oxymorphone, and noroxymorphone in human plasma by liquid chromatography-electrospray-tandem mass spectrometry

1 reference

12 December 2020

Measurement of Recovery from Outpatient General Anaesthesia with a Simple Ocular Test

1 reference

12 December 2020

Review of antifungal therapy and the severity index for assessing onychomycosis: part I.

1 reference

12 December 2020

Itraconazole decreases renal clearance of digoxin

1 reference

12 December 2020

Sex differences in morphine analgesia: an experimental study in healthy volunteers

1 reference

12 December 2020

The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.

1 reference

12 December 2020

Comparison of analgesic efficacy of oxycodone and morphine in postoperative intravenous patient-controlled analgesia

1 reference

12 December 2020

Effects of blocking CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone.

1 reference

12 December 2020

The pharmacokinetics of oxycodone in uremic patients undergoing renal transplantation.

1 reference

12 December 2020

Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in Sprague Dawley rats

1 reference

12 December 2020

Rapid and sensitive high performance liquid chromatographic method for the determination of itraconazole and its hydroxy-metabolite in human serum

1 reference

12 December 2020

The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism

1 reference

12 December 2020

Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole

1 reference

12 December 2020

Itraconazole increases plasma concentrations of quinidine

1 reference

12 December 2020

Interaction of common azole antifungals with P glycoprotein

1 reference

12 December 2020

Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone

1 reference

12 December 2020

CYP2D6 genotyping by a multiplex primer extension reaction.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolites

1 reference

12 December 2020

Controlled-release oxycodone compared with controlled-release morphine in the treatment of cancer pain: a randomized, double-blind, parallel-group study

1 reference

12 December 2020

Quantitative contribution of CYP2D6 and CYP3A to oxycodone metabolism in human liver and intestinal microsomes

1 reference

12 December 2020

Plasma concentrations of oral oxycodone are greatly increased in the elderly

1 reference

12 December 2020

Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174

1 reference

12 December 2020

The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.

1 reference

12 December 2020

Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833.

1 reference

12 December 2020

Effect of fluconazole dose on the extent of fluconazole-triazolam interaction

1 reference

12 December 2020

Response of experimental pain to analgesic drugs. 1. Morphine, aspirin, and placebo

1 reference

12 December 2020

Voriconazole drastically increases exposure to oral oxycodone

1 reference

12 December 2020

Itraconazole greatly increases plasma concentrations and effects of felodipine.

1 reference

12 December 2020

Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.

1 reference

12 December 2020

Pharmacokinetics and ventilatory effects of oxycodone before and after liver transplantation.

1 reference

12 December 2020

Treatment of invasive candidal infections: systematic review and meta-analysis

1 reference

12 December 2020

10.1007/S00228-009-0775-8

Identifiers

DOI

1 reference

10 September 2017

1 reference